EP Patent

EP4579371A3 — Devices for fluidization and delivering a powdered agent

Assigned to Boston Scientific Scimed Inc · Expires 2025-12-24 · 0y expired

What this patent protects

A medical device comprising an outlet, a container configured to store an agent, a channel in fluid communication with the outlet and the container, and an attachment member coupled to the container and movable relative to the outlet. The attachment member is configured to transi…

USPTO Abstract

A medical device comprising an outlet, a container configured to store an agent, a channel in fluid communication with the outlet and the container, and an attachment member coupled to the container and movable relative to the outlet. The attachment member is configured to transition the container between a closed configuration and an open configuration. In the closed configuration, the attachment member is positioned relative to the outlet to close the channel such that the outlet is fluidly decoupled from the container, thereby inhibiting the agent from exiting the container and entering the outlet. In the open configuration, the attachment member is positioned relative to the outlet to open the channel such that the outlet is fluidly coupled to the container, thereby allowing the agent to exit the container and enter the outlet.

Drugs covered by this patent

Patent Metadata

Patent number
EP4579371A3
Jurisdiction
EP
Classification
Expires
2025-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Boston Scientific Scimed Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.